Dr. Frick
Oberwil
Member of the board + liquidator
Individual signing authority
Günter Graubach
Basel
Partner and manager
Individual signing authority
Pharma Development Holding GmbH
Neuss(DE)
Partner
Without signing authority
Wolfgang Greb
Düsseldorf
General manager
Individual signing authority
Rudolf Syz
Arisdorf
Chairperson of the board
Joint signing authority (any two to sign)
Günter Graubach
Basel
Vice-chairperson of the board
Joint signing authority (any two to sign)
Wolfgang Greb
Neuss
Member of the board
Joint signing authority (any two to sign)
Guillaume Souliac
Paris, FR
Joint signing authority (any two to sign)
Henry Geoffrey McMillan
Royston (UK)
Individual signing authority
Timothy Wright
Yarmoth
Chairperson of the board
Individual signing authority
Nigel Goldsmith
Alvanley
Member of the board
Individual signing authority
Ann Hardy
Frodsham (UK)
Member of the board
Individual signing authority
Frank Hall
Nether Winchendon
Member of the board
Individual signing authority
Dr. Haroun Frick
Oberwil
Member of the board
Individual signing authority
Christopher Spooner
London
Chairperson of the board
Individual signing authority
Christophe Foucher
Suresnes
Member of the board
Individual signing authority
Alan Musgrave Olby
Chiddingfold, GB
Member of the board
Individual signing authority
Stephen Redman
Worthing
Member of the board
Individual signing authority
Building smart people network graph...
Fetching people and their companies
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 5862 | 26.11.2018 | 232 | 29.11.2018 | 1004508761 |
| 2 | 5010 | 05.10.2017 | 196 | 10.10.2017 | 3800393 |
| 3 | 3203 | 22.07.2014 | 142 | 25.07.2014 | 1634553 |
| 4 | 1413 | 25.03.2013 | 61 | 28.03.2013 | 7125648 |
| 5 | 5307 | 16.11.2011 | 226 | 21.11.2011 | 6424832 |
| 6 | 907 | 10.02.2010 | 32 | 16.02.2010 | 7/5498414 |
| 7 | 5345 | 14.08.2009 | 160 | 20.08.2009 | 6/5206092 |
| 8 | 1563 | 06.03.2009 | 49 | 12.03.2009 | 6/4922670 |
| 9 | 2409 | 26.05.2008 | 103 | 30.05.2008 | 6/4499882 |
| 10 | 946 | 23.02.2007 | 42 | 01.03.2007 | 5/3803126 |
Erwerb von Patenten, Lizenzen, Vermarktungs- und/oder Distributionsrechten von pharmazeutischen Produkten, deren Verwertung und Kommerzialisierung in der Schweiz und international. Die Gesellschaft kann für Dritte Dienstleistungen auf dem Gebiet der Kommerzialisierung von pharmazeutischen Produkten erbringen, sich an anderen Unternehmen beteiligen sowie Grundeigentum erwerben und veräussern.
